MAPKとmTORC1のシグナリングは,メラノーマの持続性のある細胞に細胞サイクル再侵入を可能にするため,サイクリンD1タンパク質の生産を推進するために収束する
Varuna Nangia1,2, Humza Ashraf1, Nasreen Marikar1
1Department of Biochemistry and BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303, USA.
Science signaling
|September 2, 2025
まとめ
薬剤耐性メラノーマ細胞は,ERKとmTORC1のシグナル伝達経路を再活性化することで,治療を逃れる. この収束はサイクリンD1タンパク質を増加させ,薬の脱出メカニズムを早期に予測し標的化することを可能にします.
科学分野:
- 癌 生物学
- 細胞シグナリング
- メラノマ 研究
背景:
- BRAFとMEK阻害剤で治療されたBRAF変異性メラノーマ細胞は,薬剤誘発の静止状態から脱出するために適応することができます.
- この薬の脱出のメカニズムを理解することは 癌治療の改善に不可欠です
研究 の 目的:
- BRAF変異性メラノーマ細胞が 薬物治療から逃れられる信号伝達経路と 分子機構を調査する
- 薬剤耐性を抑制するための早期のバイオマーカーと潜在的な治療標的を特定する.
主な方法:
- タイムラップ画像データから単細胞系を再構築する.
- ダイナミックシグナル伝達経路 (ERK,mTORC1) と細胞サイクル進行の分析
- CRISPRによるサイクリンD1のタグ付けにより,薬物治療を受けた細胞におけるその蓄積を追跡します.
主要な成果:
- ERKとmTORC1のシグナルの再活性化は,薬の脱出と細胞サイクルへの再侵入に必要である.
- ERKとmTORC1は,細胞サイクルコミットメントの重要なボトルネックであるサイクリンD1タンパク質の豊富さを増加させるために収束します.
- サイクルD1の蓄積は少なくとも15時間前に細胞循環に戻り,薬の脱出を早期に予測することができます.
- 肺がん細胞では同様のメカニズムが観察されましたが,大腸がん細胞ではそうではありません.
結論:
- シクリンD1はメラノーマの薬物の脱出を予測する初期バイオマーカーとして機能する.
- メラノーマにおける薬剤耐性を克服するための治療戦略として,サイクリンD1をターゲットにすることがある.
- mTORC1主導の薬の脱出メカニズムは,異なる癌タイプに部分的に一般化することが示されています.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


